UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 83

Sortiert nach

Aldosterone induces a vascular inflammatory phenotype in the rat heart

American journal of physiology. Heart and circulatory physiology, 2002-11, Vol.283 (5), p.H1802-H1810

2002

Volltextzugriff (PDF)

Transgenic Model of Aldosterone-Driven Cardiac Hypertrophy and Heart Failure

Circulation research, 2003-07, Vol.93 (1), p.69-76

2003

Volltextzugriff (PDF)

Aldosterone/salt induces renal inflammation and fibrosis in hypertensive rats

Kidney international, 2003-05, Vol.63 (5), p.1791-1800

2003

Volltextzugriff (PDF)

The evolution of aldosterone antagonists

Molecular and cellular endocrinology, 2004-03, Vol.217 (1), p.27-31

2004

Volltextzugriff (PDF)

Effects of long-term monotherapy with eplerenone, a novel aldosterone blocker, on progression of left ventricular dysfunction and remodeling in dogs with heart failure

Circulation (New York, N.Y.), 2002-12, Vol.106 (23), p.2967-2972

2002

Volltextzugriff (PDF)

Recent studies with eplerenone, a novel selective aldosterone receptor antagonist

Current Opinion in Pharmacology, 2001-04, Vol.1 (2), p.190-196

McMahon, Ellen G

2001

Volltextzugriff (PDF)

Aldosterone target organ protection by eplerenone

Molecular and cellular endocrinology, 2004-03, Vol.217 (1), p.229-238

2004

Volltextzugriff (PDF)

Structural, functional, and molecular characterization of the SHHF model of heart failure

American journal of physiology. Heart and circulatory physiology, 2002-11, Vol.283 (5), p.H1775-H1784

2002

Volltextzugriff (PDF)

Eplerenone, a new selective aldosterone blocker

Current pharmaceutical design, 2003-01, Vol.9 (13), p.1065

McMahon, Ellen G

2003

Volltextzugriff (PDF)

Molecular mechanisms of mineralocorticoid receptor antagonism by eplerenone

Mini reviews in medicinal chemistry, 2005-08, Vol.5 (8), p.709

2005

Volltextzugriff (PDF)

Role of endothelin and prostaglandins in radiocontrast-induced renal artery constriction

Kidney international, 1993-12, Vol.44 (6), p.1217-1223

1993

Volltextzugriff (PDF)

Increased activity of the hexosamine synthesis pathway in muscles of insulin-resistant ob/ob mice

American journal of physiology: endocrinology and metabolism, 1997-06, Vol.272 (6), p.E1080-E1088

1997

Volltextzugriff (PDF)

Stimulatory effect of lithium on glucose transport in rat adipocytes is not mediated by elevation of IP1

American journal of physiology: endocrinology and metabolism, 1998-08, Vol.275 (2), p.E272

1998

Volltextzugriff (PDF)

Emerging therapies for heart failure

Expert opinion on emerging drugs, 2002-10, Vol.7 (2), p.247-258

2002

Volltextzugriff (PDF)

Stimulatory effect of lithium on glucose transport in rat adipocytes is not mediated by elevation of IP 1

American journal of physiology: endocrinology and metabolism, 1998-08, Vol.275 (2), p.E272-E277

1998

Volltextzugriff (PDF)

O-21: Aldosterone/salt-induced myocardial injury: A vascular inflammatory disease

American journal of hypertension, 2001-04, Vol.14 (S1), p.8A-9A

2001

Volltextzugriff (PDF)

P-359: Eplerenone in combination with ACE inhibitor reduces post-myocardial infarction LV remodeling and maintains function

American journal of hypertension, 2001-04, Vol.14 (S1), p.150A-151A

2001

Volltextzugriff (PDF)

Conformational restriction of angiotensin II: cyclic analogs having high potency

Journal of medicinal chemistry, 1990-07, Vol.33 (7), p.1935-1940

1990

Volltextzugriff (PDF)

Synthesis and structure-activity relationships of nonpeptide, potent triazolone-based angiotensin II receptor antagonists

Journal of medicinal chemistry, 1993-07, Vol.36 (15), p.2172-2181

1993

Volltextzugriff (PDF)

Effects of SC-56525, a Potent, Orally Active Renin Inhibitor, in Salt-Depleted and Renal Hypertensive Dogs

Hypertension (Dallas, Tex. 1979), 1995-07, Vol.26 (1), p.95-100

1995

Volltextzugriff (PDF)

Development and Comparison of Two 3T3-L1 Adipocyte Models of Insulin Resistance: Increased Glucose Flux vs Glucosamine Treatment

Biochemical and biophysical research communications, 2000-07, Vol.273 (3), p.1033-1041

2000

Volltextzugriff (PDF)

Effect of EndothelinA-Receptor Antagonist BQ-123 and Phosphoramidon on Cerebral Vasospasm

Journal of cardiovascular pharmacology, 1993, Vol.22 Suppl 8 (Supplement 8), p.S332-S335

1993

Volltextzugriff (PDF)

Clinical and therapeutic implications of new peptides in hypertension

Current opinion in cardiology, 1991-10, Vol.6 (5), p.686-692

1991

Volltextzugriff (PDF)

Conformationally restricted analogs of atriopeptin(103-125) amide

Journal of medicinal chemistry, 1989-01, Vol.32 (1), p.67-72

1989

Volltextzugriff (PDF)

Myocardial and renal vascular protection with eplerenone, enalapril and coadministration in the SHHF rat

Journal of cardiac failure, 2003-10, Vol.9 (5), p.S19-S19

2003

Volltextzugriff (PDF)

1 – 25 von 83

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(77)
Mit Volltextzugriff
(71)

Publikationsform

Sprache

Englisch
(83)
Japanisch
(10)

Erscheinungsjahr

n.n

Thema

Life Sciences & Biomedicine
(51)
Science & Technology
(51)
Animals
(34)
Male
(31)
Biological And Medical Sciences
(29)
Humans
(25)
Medical Sciences
(25)
Rats
(22)
Female
(18)
Pharmacology & Pharmacy
(13)
Cardiovascular System & Cardiology
(12)
Rabbits
(11)
Blood Pressure - Drug Effects
(10)
Cardiology. Vascular System
(10)
Peripheral Vascular Disease
(10)
Adult
(9)
Muscle, Smooth, Vascular - Drug Effects
(9)
Spironolactone - Analogs & Derivatives
(9)
Aldosterone
(8)
Chemistry
(8)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Aldosterone induces a vascular inflammatory phenotype in the rat heart

Transgenic Model of Aldosterone-Driven Cardiac Hypertrophy and Heart Failure

Aldosterone/salt induces renal inflammation and fibrosis in hypertensive rats

The evolution of aldosterone antagonists

Effects of long-term monotherapy with eplerenone, a novel aldosterone blocker, on progression of left ventricular dysfunction and remodeling in dogs with heart failure

Recent studies with eplerenone, a novel selective aldosterone receptor antagonist

Aldosterone target organ protection by eplerenone

Structural, functional, and molecular characterization of the SHHF model of heart failure

Eplerenone, a new selective aldosterone blocker

Molecular mechanisms of mineralocorticoid receptor antagonism by eplerenone

Role of endothelin and prostaglandins in radiocontrast-induced renal artery constriction

Increased activity of the hexosamine synthesis pathway in muscles of insulin-resistant ob/ob mice

Stimulatory effect of lithium on glucose transport in rat adipocytes is not mediated by elevation of IP1

Emerging therapies for heart failure

Stimulatory effect of lithium on glucose transport in rat adipocytes is not mediated by elevation of IP 1

O-21: Aldosterone/salt-induced myocardial injury: A vascular inflammatory disease

P-359: Eplerenone in combination with ACE inhibitor reduces post-myocardial infarction LV remodeling and maintains function

Conformational restriction of angiotensin II: cyclic analogs having high potency

Synthesis and structure-activity relationships of nonpeptide, potent triazolone-based angiotensin II receptor antagonists

Effects of SC-56525, a Potent, Orally Active Renin Inhibitor, in Salt-Depleted and Renal Hypertensive Dogs

Development and Comparison of Two 3T3-L1 Adipocyte Models of Insulin Resistance: Increased Glucose Flux vs Glucosamine Treatment

Effect of EndothelinA-Receptor Antagonist BQ-123 and Phosphoramidon on Cerebral Vasospasm

Clinical and therapeutic implications of new peptides in hypertension

Conformationally restricted analogs of atriopeptin(103-125) amide

Myocardial and renal vascular protection with eplerenone, enalapril and coadministration in the SHHF rat

Suchergebnisse filtern